Vestcor Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925K | Buy |
2,836
+375
| +15% | +$122K | 0.03% | 518 |
|
|
2025
Q1 | $665K | Buy |
2,461
+6
| +0.2% | +$1.62K | 0.02% | 576 |
|
|
2024
Q4 | $578K | Sell |
2,455
-3
| -0.1% | -$706 | 0.02% | 626 |
|
|
2024
Q3 | $676K | Buy |
2,458
+420
| +21% | +$116K | 0.02% | 587 |
|
|
2024
Q2 | $495K | Hold |
2,038
| – | – | 0.02% | 665 |
|
|
2024
Q1 | $305K | Sell |
2,038
-755
| -27% | -$113K | 0.01% | 822 |
|
|
2023
Q4 | $535K | Sell |
2,793
-26
| -0.9% | -$4.98K | 0.02% | 639 |
|
|
2023
Q3 | $499K | Sell |
2,819
-14
| -0.5% | -$2.48K | 0.02% | 626 |
|
|
2023
Q2 | $538K | Hold |
2,833
| – | – | 0.02% | 593 |
|
|
2023
Q1 | $568K | Sell |
2,833
-12
| -0.4% | -$2.41K | 0.02% | 604 |
|
|
2022
Q4 | $676K | Hold |
2,845
| – | – | 0.02% | 580 |
|
|
2022
Q3 | $569K | Buy |
2,845
+48
| +2% | +$9.6K | 0.02% | 637 |
|
|
2022
Q2 | $408K | Buy |
2,797
+906
| +48% | +$132K | 0.02% | 739 |
|
|
2022
Q1 | $309K | Buy |
1,891
+424
| +29% | +$69.3K | 0.01% | 800 |
|
|
2021
Q4 | $249K | Sell |
1,467
-271
| -16% | -$46K | 0.01% | 794 |
|
|
2021
Q3 | $328K | Sell |
1,738
-225
| -11% | -$42.5K | 0.01% | 697 |
|
|
2021
Q2 | $333K | Buy |
+1,963
| New | +$333K | 0.01% | 733 |
|